Chemotherapy toxicity in gynecologic cancer patients with a body surface area (BSA) >2m(s) Ovarian Cancer and Us OVARIAN CANCER and US Ovarian Cancer and Us

Blog Archives: Nov 2004 - present

#ovariancancers



Special items: Ovarian Cancer and Us blog best viewed in Firefox

Search This Blog

Saturday, April 11, 2009

Chemotherapy toxicity in gynecologic cancer patients with a body surface area (BSA) >2m(s)



"...women with a BSA>2 m(2) on paclitaxel dosed by ABW do not experience excess toxicity in comparison to women on paclitaxel capped at a maximum BSA or women in published trials of adjuvant P/C. Empiric dose reduction is unnecessary and may result in suboptimal treatment...."

0 comments :

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.